logo

For the Inventor, By the Inventor

Berlin, Germany

Yukishige Nishino

This inventor holds 28 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Schering Aktiengesellschaft. Active years: 1976-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukishige Nishino. Retrieved from https://idiyas.com/inventor/yukishige-nishino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 92.9

 

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 190(Granted Patents)


Company Filing History:

goldMedal28 out of 1,409 
 
Schering Aktiengesellschaft
 patents

Years Active: 1976-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzocycloheptenes
Aromatase Inhibitors
Pharmaceutical Preparations
Estratrienes
Antiandrogenic Compounds
Functionalized Azoles
Imidazoles
Steroids
28 patents (USPTO):Explore Patents
1. 7145015 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents (2006-12-05),
2. 6878750 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2005-04-12),
3. 6780855 - 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS (2004-08-24),
4. 6495607 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2002-12-17),
5. 6288051 - 7 &agr;-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 &agr;(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents (2001-09-11),
6. 6271403 - 7&agr;-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7&agr;-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents (2001-08-07),
7. 5986115 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-11-16),
8. 5866560 - 7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, (1999-02-02),
9. 5807899 - Triphenylethylenes, process for their production, pharmaceutical (1998-09-15),
10. 5569652 - Dihydrospirorenone as an antiandrogen (1996-10-29),
11. 5502046 - 11.beta.-substituted 14,17-ethanoestratrienes, process for their (1996-03-26),
12. 5411982 - Cycloalkylene azoles, and their use as aromatase inhibitors (1995-05-02),
13. 5389624 - Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids (1995-02-14),
14. 5344834 - Functionalized vinyl azoles and methods of use (1994-09-06),
15. 5280035 - Cycloalkylene azoles and their use as aromatase inhibitors (1994-01-18),

Title: **Yukishige Nishino: A Pioneer in Pharmaceutical Innovations**

Introduction

Yukishige Nishino is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 28 patents, he has developed groundbreaking compounds that have the potential to transform medical treatments, particularly in the area of bone health.

Latest Patents

Nishino's latest patents focus on benzocycloheptenes, including a novel process for their production and pharmaceutical preparations that contain these compounds. His work highlights the selective estrogenic activity of these benzocycloheptenes, which are particularly promising for the prophylaxis and therapy of osteoporosis. The detailed description of this invention encompasses compounds of general formula I, where specific substituents R, R, and Y are defined. The implications of these discoveries could lead to the development of effective pharmaceutical agents addressing bone density issues.

Career Highlights

Throughout his career, Yukishige Nishino has established himself as a leading figure in his field. His extensive research and innovative approach have earned him a significant number of patents, reflecting his dedication to advancing pharmaceutical science. His contributions have not only broadened the scope of existing treatments but also opened new avenues for future research and development.

Collaborations

In his endeavors, Nishino has collaborated with esteemed colleagues such as Rolf Bohlmann and Martin Schneider. These partnerships have allowed for the exchange of ideas and expertise, fostering a collaborative environment that promotes innovation. Together, they have worked on multiple projects that underline the importance of teamwork in achieving significant advancements in research and development.

Conclusion

Yukishige Nishino's contributions to the pharmaceutical industry, particularly through his latest inventions related to benzocycloheptenes, set a remarkable example of innovative thinking. His work not only showcases his expertise but also exemplifies how collaboration among talented individuals can lead to groundbreaking advancements in healthcare. As he continues his journey, the impact of his innovations will undoubtedly resonate within the scientific community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…